Trial Profile
Minimal Optimal Dose of Sugammadex in Elective Surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2021
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- Acronyms SDDS
- 01 Aug 2021 Primary endpoint has not been met. (Evaluate the recovery time of the ratio 0.9.), as per Results published in the European Journal of Anaesthesiology
- 01 Aug 2021 Results published in the European Journal of Anaesthesiology
- 14 Feb 2019 Status changed from recruiting to completed.